HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer

Publication: Research - peer-reviewJournal article

DOI

  • Helen Ross-Adams
    Helen Ross-AdamsDepartment of Oncology, Cancer Research UK Cambridge Research Institute, University of Cambridge
  • Stephen J. Ball
    Stephen J. BallProstate Cancer Research Centre, University College London, London, UK.
  • Kate Lawrenson
    Kate LawrensonDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, USA.
  • Silvia Halim
    Silvia HalimDepartment of Oncology, Cancer Research UK Cambridge Research Institute, University of Cambridge
  • Roslin Russell
    Roslin RussellDepartment of Oncology, Cancer Research UK Cambridge Research Institute, University of Cambridge
  • Claire Wells
    Claire WellsDivision of Cancer Studies, Cancer Epidemiology Group, King's College London
  • Siri H Strand
    Siri H Strand
  • Torben F Ørntoft
  • Melissa C Larson
    Melissa C LarsonMolecular Medicine Program, Mayo Clinic, Rochester, USA.
  • Sebastian M Armasu
    Sebastian M ArmasuMolecular Medicine Program, Mayo Clinic, Rochester, USA.
  • Charles E Massie
    Charles E MassieDepartment of Oncology, Cancer Research UK Cambridge Research Institute, University of Cambridge
  • Mohammad Asim
    Mohammad AsimDepartment of Oncology, Cancer Research UK Cambridge Research Institute, University of Cambridge
  • Martin M Mortensen
    Martin M Mortensen
  • Michael Borre
  • Kathryn Woodfine
    Kathryn WoodfineDepartment of Oncology, Cancer Research UK Cambridge Research Institute, University of Cambridge
  • Anne Y Warren
    Anne Y WarrenDepartment of Pathology, Addenbrooke's Hospital, Cambridge, UK.
  • Alastair D Lamb
    Alastair D LambDepartment of Urology, Addenbrooke's Hospital, Cambridge, UK.
  • Jonathan Kay
    Jonathan KayMolecular Diagnostics and Therapeutics Group, University College London, London, UK.
  • Hayley Whitaker
    Hayley WhitakerMolecular Diagnostics and Therapeutics Group, University College London, London, UK.
  • Antonio Ramos-Montoya
    Antonio Ramos-MontoyaDepartment of Oncology, Cancer Research UK Cambridge Research Institute, University of Cambridge
  • Adele Murrell
    Adele MurrellDepartment of Biology and Biochemistry, University of Bath, Centre for Regenerative Medicine, Claverton Down, Bath, UK.
  • Karina D Sørensen
  • Brooke L Fridley
    Brooke L FridleyDepartment of Biostatistics, University of Kansas Medical Center, Kansas City, KS, USA.
  • Ellen L Goode
    Ellen L GoodeMolecular Medicine Program, Mayo Clinic, Rochester, USA.
  • Simon A Gayther
    Simon A GaytherDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, USA.
  • John R Masters
    John R MastersProstate Cancer Research Centre, University College London, London, UK.
  • David E Neal
    David E NealDepartment of Urology, Addenbrooke's Hospital, Cambridge, UK.
  • Ian G Mills
    Ian G MillsProstate Cancer UK/Movember Centre of Excellence for Prostate Cancer Research, Centre for Cancer Research and Cell Biology, Queens University Belfast, Belfast, UK.
Original languageEnglish
JournalOncoTarget
Volume7
Issue number46
Pages (from-to)74734-74746
Number of pages13
ISSN1949-2553
DOIs
StatePublished - 15 Nov 2016

    Keywords

  • Journal Article

See relations at Aarhus University Citationformats

ID: 110216784